🇺🇸 FDA
Patent

US 8957097

Hemi-phorboxazole A derivatives and methods of their use

granted A61PA61P31/10A61P35/00

Quick answer

US patent 8957097 (Hemi-phorboxazole A derivatives and methods of their use) held by The Regents of the University of California expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P31/10, A61P35/00